Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Meropenem And Vaborbactam

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics

    10 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230710869070/en

    BUSINESSWIRE
    10 Jul 2023
    Share Share
    Menarini and SciClone Sign Agreement to Develop and Commercialize Vaborem
    Menarini and SciClone Sign Agreement to Develop and Commercialize Vaborem

    21 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/in/news-releases/menarini-and-sciclone-sign-exclusive-licensing-agreement-to-develop-and-commercialize-vaborem-in-china-to-treat-antimicrobial-resistant-infections-301628124.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share
    MENARINI RICERCHE ANNOUNCES THE LATEST FINDINGS OF ITS VABOREM™
    MENARINI RICERCHE ANNOUNCES THE LATEST FINDINGS OF ITS VABOREM™

    09 Jul 2020

    // PRESS RELEASE

    https://www.menarini.com/Home/Menarini-News/News/News-details/ArticleId/2695/Menarini-Ricerche-Announces-the-Latest-Findings-of-its-Vaborem-and-Quofenix-Clinical-Studies

    PRESS RELEASE
    09 Jul 2020
    Share Share
    Rempex's Vabomere (meropenem trihydrate, vaborbactam) Receives Approval in Europe
    Rempex's Vabomere (meropenem trihydrate, vaborbactam) Receives Approval in Europe

    19 Dec 2018

    // EMA

    https://www.ema.europa.eu/documents/product-information/vabomere-epar-product-information_en.pdf

    EMA
    19 Dec 2018
    Share Share
    Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline
    Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline

    23 Oct 2018

    // ENDPTS

    https://endpts.com/medicines-co-execs-grab-a-33m-a-round-to-spin-out-an-infectious-disease-outfit-with-a-pipeline/

    ENDPTS
    23 Oct 2018
    Share Share
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin

    11 Oct 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-group-anuncia-un-acuerdo-comercial-para-vabomere-orbactiv-y-minocin-en-68-pa%C3%ADses-861609999.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share